Ausdal Financial Partners’s Transmedics TMDX Stock Holding History

Ausdal Financial Partners’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$290K	Buy	+2,920	New	+$381K	0.01%	788

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ausdal Financial Partners's TMDX Position: Q1 2026 in Review

Ausdal Financial Partners opened a new position in Transmedics (TMDX) in Q1 2026: 2,920 shares worth $290K. The stake represents 0.01% of the portfolio and ranks #788 among its holdings.

414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Ausdal Financial Partners held 2,920 shares of Transmedics worth $290K as of Q1 2026.
Transmedics was a new Ausdal Financial Partners position in Q1 2026.
Transmedics made up 0.01% of Ausdal Financial Partners's portfolio in Q1 2026, its #788 holding.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Ausdal Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.